[1] |
Dinh QN, Chrissobolis S, Diep H, et al. Advanced atherosclerosis is associated with inflammation, vascular dysfunction and oxidative stress, but not hypertension [J]. Pharmacol Res, 2017, (116):70-76. DOI: 10.1016/j.phrs.2016.12.032.
|
[2] |
Dinh QN, Drummond GR , Sobey CG , et al. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension[J]. Biomed Res Int, 2014, 2014::406960. DOI: 10.1155/2014/406960.
|
[3] |
Guzik TJ, Touyz RM. Oxidative stress, inflammation, and vascular aging in hypertension[J]. Hypertension, 2017, 70(4):660-667. DOI: 10.1161/HYPERTENSIONAHA.117.07802.
|
[4] |
Siti HN , Kamisah Y , Kamsiah J. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)[J].Vascul Pharmacol,2015,(71):40-56.DOI:10.1016/j.vph.2015. 03.005.
|
[5] |
Mancini A, Di Segni C, Raimondo S, et al. Thyroid hormones, oxidative stress, and inflammation[J]. Mediators Inflamm, 2016, (2016): 6757154. DOI: 10.1155/2016/6757154.
|
[6] |
Płóciennikowska A, Hromada-Judycka A, Borzęcka K, et al. Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling[J]. Cell Mol Life Sci, 2015, 72(3):557–581. DOI: 10.1007/s00018-014-1762-5.
|
[7] |
Lugrin J, Rosenblatt-Velin N , Parapanov R , et al. The role of oxidative stress during inflammatory processes[J]. Biol Chem, 2014, 395(2):203-230. DOI: 10.1515/hsz-2013-0241.
|
[8] |
Das BC, Thapa P, Karki R, et al. Retinoic acid signaling pathways in development and diseases[J]. Bioorg Med Chem, 2014, 22(2):673-683. DOI:10.1016/j.bmc.2013.11.025.
|
[9] |
Penny HL, Prestwood TR, Bhattacharya N, et al. Restoring retinoic acid attenuates intestinal inflammation and tumorigenesis in APCMin/+ Mice[J]. Cancer Immunol Res, 2016, 4(11):917-926. DOI: 10.1158/2326-6066.CIR-15-0038.
|
[10] |
Tokarz P, Piastowska-Ciesielska AW, Kaarniranta K, et al. All-Trans Retinoic Acid Modulates DNA Damage Response and the Expression of the VEGF-A and MKI67 Genes in ARPE-19 Cells Subjected to Oxidative Stress[J]. Int J Mol Sci, 2016, 17(6):898. DOI: 10.3390/ijms17060898.
|
[11] |
Yuyun MF, Ng LL, André Ng G. Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahy drofolate in cardiovascular disease. Where are we with therapy[J]? Microvasc Res,2018,(119):7-12. DOI:10.1016/j.mvr. 2018. 03.012.
|
[12] |
Deng G, Long Y, Yu YR, et al. Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK–eNOS Pathway[J]. Int J Obes(Lond), 2009, 34(1):165-171. DOI:10.1038/ijo.2009.205.
|
[13] |
Wadley AJ, Veldhuijzen van Zanten JJ, Aldred S. The interactions of oxidative stress and inflammation with vascular dysfunction in ageing: the vascular health triad[J]. Age, 2013, 35(3):705-718. DOI: 10.1007/s11357-012-9402-1.
|